101 related articles for article (PubMed ID: 23106494)
61. Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms.
Rosin C; Bates TE; Skaper SD
J Neurochem; 2004 Sep; 90(5):1173-85. PubMed ID: 15312172
[TBL] [Abstract][Full Text] [Related]
62. An electron microscopic study of the effects of tetanus toxin on motoneurons of the rat spinal cord.
Yates JC; Yates RD
J Ultrastruct Res; 1966 Oct; 16(3):382-94. PubMed ID: 5929368
[No Abstract] [Full Text] [Related]
63. Protection of cultured spinal motor neurons by estradiol.
Nakamizo T; Urushitani M; Inoue R; Shinohara A; Sawada H; Honda K; Kihara T; Akaike A; Shimohama S
Neuroreport; 2000 Nov; 11(16):3493-7. PubMed ID: 11095506
[TBL] [Abstract][Full Text] [Related]
64. The C-terminal fragment of the heavy chain of the tetanus toxin (Hc-TeTx) improves motor activity and neuronal morphology in the limbic system of aged mice.
Vazquez-Roque R; Pacheco-Flores M; Penagos-Corzo JC; Flores G; Aguilera J; Treviño S; Guevara J; Diaz A; Venegas B
Synapse; 2021 Jun; 75(6):e22193. PubMed ID: 33141999
[TBL] [Abstract][Full Text] [Related]
65. FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases.
Mojsilovic-Petrovic J; Nedelsky N; Boccitto M; Mano I; Georgiades SN; Zhou W; Liu Y; Neve RL; Taylor JP; Driscoll M; Clardy J; Merry D; Kalb RG
J Neurosci; 2009 Jun; 29(25):8236-47. PubMed ID: 19553463
[TBL] [Abstract][Full Text] [Related]
66. T-588 protects motor neuron death against glutamate-induced neurotoxicity.
Iwasaki Y; Ichikawa Y; Igarasi O; Aoyagi J; Konno S; Ikeda K; Iguchi H; Kawabe S; Marubuchi S; Ono S
Neurochem Res; 2003 Dec; 28(12):1829-32. PubMed ID: 14649724
[TBL] [Abstract][Full Text] [Related]
67. Ghrelin protects spinal cord motoneurons against chronic glutamate excitotoxicity by inhibiting microglial activation.
Lee S; Kim Y; Li E; Park S
Korean J Physiol Pharmacol; 2012 Feb; 16(1):43-8. PubMed ID: 22416219
[TBL] [Abstract][Full Text] [Related]
68. Characterization of recombinant tetanus toxin derivatives suitable for vaccine development.
Figueiredo D; Turcotte C; Frankel G; Li Y; Dolly O; Wilkin G; Marriott D; Fairweather N; Dougan G
Infect Immun; 1995 Aug; 63(8):3218-21. PubMed ID: 7622252
[TBL] [Abstract][Full Text] [Related]
69. Motoneuron uptake from the circulation of the binding fragment of tetanus toxin.
Fishman PS; Carrigan DR
Arch Neurol; 1988 May; 45(5):558-61. PubMed ID: 3358710
[TBL] [Abstract][Full Text] [Related]
70. Diagnostic and therapeutic potential of tetanus toxin-derivatives in neurological diseases.
Kassa R; Monterroso V; David LL; Tshala-Katumbay D
J Mol Neurosci; 2013 Nov; 51(3):788-91. PubMed ID: 23842888
[TBL] [Abstract][Full Text] [Related]
71. Medullary actions of tetanus toxin. An electrophysiological study in man.
Bratzlavsky M; vander Eecken H
Arch Neurol; 1976 Nov; 33(11):783-5. PubMed ID: 985157
[TBL] [Abstract][Full Text] [Related]
72. The effect of tetanus toxin on boutons terminaux.
Illis LS; Mitchell J
Brain Res; 1970 Mar; 18(2):283-95. PubMed ID: 4101873
[No Abstract] [Full Text] [Related]
73. Interaction between a Novel Oligopeptide Fragment of the Human Neurotrophin Receptor TrkB Ectodomain D5 and the C-Terminal Fragment of Tetanus Neurotoxin.
Candalija A; Scior T; Rackwitz HR; Ruiz-Castelan JE; Martinez-Laguna Y; Aguilera J
Molecules; 2021 Jun; 26(13):. PubMed ID: 34208805
[TBL] [Abstract][Full Text] [Related]
74. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Autophagy; ; . PubMed ID: 33634751
[TBL] [Abstract][Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
